Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis

Immunity to SARS‐CoV‐2 induced by infection or vaccination - Castro Dopico - 2022 - Journal of Internal Medicine - Wiley Online Library

COVID-19 and Other Viral Infections in Patients With Hematologic Malignancies

Pathogens, Free Full-Text

Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study - The Lancet Rheumatology

BNT162b2 mRNA COVID-19 vaccination in immunocompromised patients: A prospective cohort study - eClinicalMedicine

Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study - The Lancet Oncology

Frontiers Emerging viral infections in immunocompromised patients: A great challenge to better define the role of immune response

Cancer in the Midst of COVID-19, A Report

Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis: Trends in Molecular Medicine

Covid-19 Vaccines — Immunity, Variants, Boosters

Antibody response after vaccination against SARS-CoV-2 in adults with hematological malignancies: a systematic review and meta-analysis